(Q45095646)

English

Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice

scientific article published in October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 December 2017

Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice (English)

1 reference

Europe PubMed Central

9 December 2017

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Hangyuan Guo

1

1 reference

Europe PubMed Central

9 December 2017

Haitao Lv

2

1 reference

Europe PubMed Central

9 December 2017

Weiliang Tang

3

1 reference

Europe PubMed Central

9 December 2017

Jufang Chi

4

1 reference

Europe PubMed Central

9 December 2017

Longbin Liu

5

1 reference

Europe PubMed Central

9 December 2017

Fukang Xu

6

1 reference

Europe PubMed Central

9 December 2017

Zheng Ji

7

1 reference

Europe PubMed Central

9 December 2017

Xiaoya Zhai

8

1 reference

Europe PubMed Central

9 December 2017

Fang Peng

9

1 reference

Europe PubMed Central

9 December 2017

publication date

1 October 2012

1 reference

Europe PubMed Central

9 December 2017

Cardiovascular Drugs and Therapy

1 reference

Europe PubMed Central

9 December 2017

26

1 reference

Europe PubMed Central

9 December 2017

5

1 reference

Europe PubMed Central

9 December 2017

375-382

1 reference

Europe PubMed Central

9 December 2017

Insulin resistance concepts

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Cardiovascular risk continuum: implications of insulin resistance and diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Do statins beneficially or adversely affect glucose homeostasis?

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Differential metabolic effects of distinct statins.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

No effect of simvastatin treatment on insulin sensitivity in patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Approximate equivalent rosuvastatin doses for temporary statin interchange programs

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Bacterial and mammalian HMG-CoA reductases: related enzymes with distinct architectures

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Comparative pharmacology of rosuvastatin

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Role of IRS-2 in insulin and cytokine signalling

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Disruption of IRS-2 causes type 2 diabetes in mice

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Molecular mechanisms of insulin resistance that impact cardiovascular biology

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

The IRS-signalling system during insulin and cytokine action

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Mechanism of activation and function of protein kinase B.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

AKT/PKB signaling: navigating downstream

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

A complex interplay between Akt, TSC2 and the two mTOR complexes

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Glucose transporter and Na+/glucose cotransporter as molecular targets of anti-diabetic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

The role of GLUT2 in dietary sugar handling.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Functional properties and genomics of glucose transporters

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase- dependent mechanism.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Discovery, biochemistry and biology of lovastatin

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Efficacy and safety of pitavastatin in Japanese patients with hypercholesterolemia: LIVES study and subanalysis

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6406-0

21 January 2018

Identifiers

10.1007/S10557-012-6406-0

1 reference

Europe PubMed Central

9 December 2017

1 reference

Europe PubMed Central

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45095646&oldid=2065737106"